Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    March 2017
  1. LIU Y, Scherlag BJ, Fan Y, Xia W, et al
    Acetylcholine-Atropine Interactions: Paradoxical Effects on Atrial Fibrillation Inducibility.
    J Cardiovasc Pharmacol. 2017 Mar 21. doi: 10.1097/FJC.0000000000000484.
    PubMed     Text format     Abstract available


    February 2017
  2. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2017;69:118-126.
    PubMed     Text format     Abstract available


    December 2016
  3. SILVA AF, Bonatti R, Batatinha J, Nearing BD, et al
    The Selective Late Sodium Current Inhibitor, Eleclazine, Unlike Amiodarone, Does Not Alter Defibrillation Threshold or Dominant Frequency of Ventricular Fibrillation.
    J Cardiovasc Pharmacol. 2016 Dec 28. doi: 10.1097/FJC.0000000000000455.
    PubMed     Text format     Abstract available


    November 2016
  4. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  5. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2016 Nov 22. doi: 10.1097/FJC.0000000000000448.
    PubMed     Text format     Abstract available


  6. BEATCH GN, Bhirangi K, Juul-Moller S, Rustige J, et al
    Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in the Asia-Pacific region: a phase 3 randomized controlled trial.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  7. GARCIA-PEDRAZA JA, Garcia M, Martin ML, Eleno N, et al
    Chronic sarpogrelate treatment reveals 5-HT7 receptor in the serotonergic inhibition of the rat vagal bradycardia.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  8. SAIRAKU A, Nakano Y, Suenari K, Tokuyama T, et al
    Dexmedetomidine depresses sinoatrial and atrioventricular nodal function without any change in atrial fibrillation inducibility.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  9. WEI X, Zhu A, Zhang Y, Yao S, et al
    Pre- and delayed treatments with ranolazine ameliorate ventricular arrhythmias and Nav1.5 downregulation in ischemic/reperfused rat hearts.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  10. AMINO M, Inokuchi S, Yoshioka K, Nakagawa Y, et al
    Does antiarrhythmic drug during cardio-pulmonary resuscitation improve the one-month survival: The SOS-KANTO 2012 study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  11. ZAMAN JA, Baykaner T, Narayan SM
    New Mechanism-based Approaches to Ablating Persistent AF: Will Drug Therapy Soon Be Obsolete?
    J Cardiovasc Pharmacol. 2016;67:1-8.
    PubMed     Text format     Abstract available


    December 2015
  12. ZHANG L, Gao S
    Systematic Review and Meta-analysis of Atrial Fibrillation Prophylaxis following Lung Surgery.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  13. HOEKER GS, Hanafy MA, Oster RA, Bers DM, et al
    Reduced Arrhythmia Inducibility with Calcium/Calmodulin-Dependent Protein Kinase II Inhibition in Heart Failure Rabbits.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  14. LU Y, Sun J, Zhou X, Zhang L, et al
    The effect of low-level vagus nerve stimulation on cardiac remodeling in a rapid atrial pacing-induced canine model of atrial fibrillation.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  15. YU HD, Xia S, Zha CQ, Deng SB, et al
    Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.
    J Cardiovasc Pharmacol. 2015;65:587-92.
    PubMed     Text format     Abstract available


    February 2015
  16. HUANG J, Lin YC, Hileman S, Martin KH, et al
    PP2 prevents isoproterenol stimulation of cardiac pacemaker activity.
    J Cardiovasc Pharmacol. 2015;65:193-202.
    PubMed     Text format     Abstract available


    January 2015
  17. GHOLAMZADEH A, Amini S, Mohammadpour AH, Vahabzadeh M, et al
    Erythropoietin reduces post-PCI arrhythmias in patients with ST-elevation myocardial infarction.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: